no injection glp 1 Weight Loss Medications GLP-1 Weight Loss Options |
Description
Patients aged 66 years with at least 1 year of follow-up were included if they had continuous healthcare coverage and medication data
HR = 0.86
In the past 5 months, the patient has continued to work on Mast Cell Activation Syndrome (MCAS)/antihistamine treatment, and she has found she genuinely feels well again for the first time in a long time
10.1007/S00592-018-1271-3 63 ShaoS.XuQ
2025;48:zsae280
Medication Alone is Not Enough
